Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study

Autor:	Minari, Roberta, Mazzaschi, Giulia, Bordi, Paola, Gnetti, Letizia, Alberti, Giorgia, Altimari, Annalisa, Gruppioni, Elisa, Sperandi, Francesca, Parisi, Claudia, Guaitoli, Giorgia, Bettelli, Stefania, Longo, Lucia, Bertolini, Federica, Pagano, Maria, Bonelli, Candida, Tagliavini, Elena, Nicoli, Davide, Ubiali, Alessandro, Zangrandi, Adriano, Trubini, Serena, Proietto, Manuela, Fiorentino, Michelangelo, Tiseo, Marcello
Zdroj:	In Clinical Lung Cancer September 2020 21(5):e464-e473
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect